Krabbe Disease Market is segmented By Therapeutics (Gene Therapy (PBKR03, etc.), Stem Cell Transplants), By Diagnostics (Newborn Screening, Genetic Te....
Market Size in USD
CAGR8.51%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.51% |
Market Concentration | High |
Major Players | Magenta Therapeutics, Passage Bio, Forge Biologics, Krystal Biotech, Orchard Therapeutics |
The Krabbe disease market is estimated to be valued at USD 488.3 Mn in 2024 and is expected to reach USD 864.7 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.51% from 2024 to 2031. The increased research and development of therapies for the treatment of the rare genetic disorder Krabbe disease is driving the growth of this market.